 |
0 Diseases |  |
37 Trials |
|
37 Trials |  |
1094 News |  |
| «12...891011121314151617181920 |
- Tekturna (aliskiren) / PDL
New P2 trial: Aliskiren vs Hydrochlorothiazide in Hypertensive Type II Diabetic Patients on Resistance Arteries (clinicaltrials.gov) - Nov 4, 2011
P2, N=40, Suspended, Sponsor: Sir Mortimer B. Davis - Jewish General Hospital
- |||||| valsartan / Generic mfg.
Enrollment open: Safety and Tolerability of Valsartan in Children 6 to 17 Years of Age (clinicaltrials.gov) - Sep 18, 2011
P3, N=150, Recruiting, Sponsor: Novartis Pharmaceuticals
Not yet recruiting --> Recruiting
- |||| Tekamlo (aliskiren/amlodipine) / Novartis, Tekturna (aliskiren) / PDL
Trial completion, Combination therapy: ACADEMY: Efficacy and Safety of Combination Therapy of Aliskiren/Amlodipine or Aliskiren/Amlodipine/Hydrochlorothiazide in Patients With Stage II Hypertension (clinicaltrials.gov) - Aug 21, 2011
P4, N=230, Completed, Sponsor: Novartis
Not yet recruiting --> Recruiting Recruiting --> Completed
- |||||||||| Bystolic (nebivolol) / Menarini, AbbVie
New P3 trial, Combination therapy: Combination of Nebivolol and Valsartan Given as Free Tablets for Stage 1 or Stage 2 Hypertension (clinicaltrials.gov) - Aug 10, 2011
P3, N=812, Completed, Sponsor: Forest Laboratories